Literature DB >> 7068686

Studies of in vitro transcription by calf thymus RNA polymerase II using a novel duplex DNA template.

T R Kadesch, M J Chamberlin.   

Abstract

Addition of 10 to 100 oligodeoxycytidylate residues to the 3'-OH termini of T7 bacteriophage DNA produces a highly efficient template for transcription in vitro with purified calf thymus RNA polymerase II. Transcription initiates rapidly and selectively at the oligo (dC) ends of such a template and essentially all of the active RNA polymerase II molecules are then committed to a long period of RNA chain elongation. This allows the direct study of the RNA chain elongation and termination reactions and also permits determination of the concentration of active RNA polymerase II that is present. From 15 to 25% of the RNA polymerase molecules in our current preparations are active in these reactions. RNA chain elongation by calf thymus RNA polymerase II is relatively slow (7 nucleotides/s) even at saturating substrate concentrations. The in vitro elongation process appears to be discontinuous, with elongating polymerase molecules pausing for significant periods at certain sequences along the DNA. There is a low, but measurable frequency of RNA chain termination at some sites; however, the majority of elongating transcripts can grow to large sizes (over 6000 nucleotides). Surprisingly, over 60% of the active calf thymus RNA polymerase II molecules form a long DNA-RNA hybrid during in vitro transcription and displace the nontranscribed DNA from the template to produce a characteristic split end structure. DNA-RNA hybrids are also formed during transcription by RNA polymerase II from duplex DNA templates lacking 3' oligo(dC) tails, which takes place predominantly at single strand breaks or ends. Thus the transcriptional elongation reaction carried out by calf thymus RNA polymerase II in vitro differs in several respects from that which must take place in vivo.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7068686

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

1.  Non-templated addition of nucleotides to the 3' end of nascent RNA during RNA editing in Physarum.

Authors:  Y W Cheng; L M Visomirski-Robic; J M Gott
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

Review 2.  Transcription elongation factor SII.

Authors:  M Wind; D Reines
Journal:  Bioessays       Date:  2000-04       Impact factor: 4.345

3.  Strong natural pausing by RNA polymerase II within 10 bases of transcription start may result in repeated slippage and reextension of the nascent RNA.

Authors:  Mahadeb Pal; Donal S Luse
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

4.  Analysis of gene induction and arrest site transcription in yeast with mutations in the transcription elongation machinery.

Authors:  M Wind-Rotolo; D Reines
Journal:  J Biol Chem       Date:  2001-01-19       Impact factor: 5.157

5.  XPB, a subunit of TFIIH, is a target of the natural product triptolide.

Authors:  Denis V Titov; Benjamin Gilman; Qing-Li He; Shridhar Bhat; Woon-Kai Low; Yongjun Dang; Michael Smeaton; Arnold L Demain; Paul S Miller; Jennifer F Kugel; James A Goodrich; Jun O Liu
Journal:  Nat Chem Biol       Date:  2011-01-30       Impact factor: 15.040

6.  Use of RNA yeast polymerase II mutants in studying transcription elongation.

Authors:  Daniel Reines
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

7.  Transcription termination by RNA polymerase III: uncoupling of polymerase release from termination signal recognition.

Authors:  F E Campbell; D R Setzer
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

8.  Efficient and rapid nucleosome traversal by RNA polymerase II depends on a combination of transcript elongation factors.

Authors:  Donal S Luse; Lisa C Spangler; Andrea Újvári
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

9.  RNA polymerase II elongation complex. Elongation complexes purified using an anti-RNA antibody do not contain initiation factor alpha.

Authors:  D Reines
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

10.  Dissection of transcription factor TFIIF functional domains required for initiation and elongation.

Authors:  S Tan; R C Conaway; J W Conaway
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.